Robustness and dosimetric verification of hippocampal-sparing craniospinal pencil beam scanning proton plans for pediatric medulloblastoma
© 2024 The Authors..
Background and Purpose: Hippocampal-sparing (HS) is a method that can potentially reduce late cognitive complications for pediatric medulloblastoma (MB) patients treated with craniospinal proton therapy (PT). The aim of this study was to investigate robustness and dosimetric plan verification of pencil beam scanning HS PT.
Materials and Methods: HS and non-HS PT plans for the whole brain part of craniospinal treatment were created for 15 pediatric MB patients. A robust evaluation of the plans was performed. Plans were recalculated in a water phantom and measured field-by-field using an ion chamber detector at depths corresponding to the central part of hippocampi. All HS and non-HS fields were measured with the standard resolution of the detector and in addition 16 HS fields were measured with high resolution. Measured and planned dose distributions were compared using gamma evaluation.
Results: The median mean hippocampus dose was reduced from 22.9 Gy (RBE) to 8.9 Gy (RBE), while keeping CTV V95% above 95 % for all nominal HS plans. HS plans were relatively robust regarding hippocampus mean dose, however, less robust regarding target coverage and maximum dose compared to non-HS plans. For standard resolution measurements, median pass rates were 99.7 % for HS and 99.5 % for non-HS plans (p < 0.001). For high-resolution measurements, median pass rates were 100 % in the hippocampus region and 98.2 % in the surrounding region.
Conclusions: A substantial reduction of dose in the hippocampus region appeared feasible. Dosimetric accuracy of HS plans was comparable to non-HS plans and agreed well with planned dose distribution in the hippocampus region.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:29 |
|---|---|
| Enthalten in: |
Physics and imaging in radiation oncology - 29(2024) vom: 01. Jan., Seite 100555 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Edvardsson, Anneli [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Craniospinal irradiation |
|---|
| Anmerkungen: |
Date Revised 27.02.2024 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
|---|
| doi: |
10.1016/j.phro.2024.100555 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM368954021 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM368954021 | ||
| 003 | DE-627 | ||
| 005 | 20240229164958.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240229s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.phro.2024.100555 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1309.xml |
| 035 | |a (DE-627)NLM368954021 | ||
| 035 | |a (NLM)38405431 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Edvardsson, Anneli |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Robustness and dosimetric verification of hippocampal-sparing craniospinal pencil beam scanning proton plans for pediatric medulloblastoma |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Revised 27.02.2024 | ||
| 500 | |a published: Electronic-eCollection | ||
| 500 | |a Citation Status PubMed-not-MEDLINE | ||
| 520 | |a © 2024 The Authors. | ||
| 520 | |a Background and Purpose: Hippocampal-sparing (HS) is a method that can potentially reduce late cognitive complications for pediatric medulloblastoma (MB) patients treated with craniospinal proton therapy (PT). The aim of this study was to investigate robustness and dosimetric plan verification of pencil beam scanning HS PT | ||
| 520 | |a Materials and Methods: HS and non-HS PT plans for the whole brain part of craniospinal treatment were created for 15 pediatric MB patients. A robust evaluation of the plans was performed. Plans were recalculated in a water phantom and measured field-by-field using an ion chamber detector at depths corresponding to the central part of hippocampi. All HS and non-HS fields were measured with the standard resolution of the detector and in addition 16 HS fields were measured with high resolution. Measured and planned dose distributions were compared using gamma evaluation | ||
| 520 | |a Results: The median mean hippocampus dose was reduced from 22.9 Gy (RBE) to 8.9 Gy (RBE), while keeping CTV V95% above 95 % for all nominal HS plans. HS plans were relatively robust regarding hippocampus mean dose, however, less robust regarding target coverage and maximum dose compared to non-HS plans. For standard resolution measurements, median pass rates were 99.7 % for HS and 99.5 % for non-HS plans (p < 0.001). For high-resolution measurements, median pass rates were 100 % in the hippocampus region and 98.2 % in the surrounding region | ||
| 520 | |a Conclusions: A substantial reduction of dose in the hippocampus region appeared feasible. Dosimetric accuracy of HS plans was comparable to non-HS plans and agreed well with planned dose distribution in the hippocampus region | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Craniospinal irradiation | |
| 650 | 4 | |a Hippocampal-sparing | |
| 650 | 4 | |a Medulloblastoma | |
| 650 | 4 | |a Pediatrics | |
| 650 | 4 | |a Proton therapy | |
| 650 | 4 | |a Quality assurance | |
| 700 | 1 | |a Gorgisyan, Jenny |e verfasserin |4 aut | |
| 700 | 1 | |a Andersson, Karin M |e verfasserin |4 aut | |
| 700 | 1 | |a Vallhagen Dahlgren, Christina |e verfasserin |4 aut | |
| 700 | 1 | |a Dasu, Alexandru |e verfasserin |4 aut | |
| 700 | 1 | |a Gram, Daniel |e verfasserin |4 aut | |
| 700 | 1 | |a Björk-Eriksson, Thomas |e verfasserin |4 aut | |
| 700 | 1 | |a Munck Af Rosenschöld, Per |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Physics and imaging in radiation oncology |d 2017 |g 29(2024) vom: 01. Jan., Seite 100555 |w (DE-627)NLM277257158 |x 2405-6316 |7 nnns |
| 773 | 1 | 8 | |g volume:29 |g year:2024 |g day:01 |g month:01 |g pages:100555 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.phro.2024.100555 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 29 |j 2024 |b 01 |c 01 |h 100555 | ||